for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Kobayashi Pharmaceutical Co Ltd

4967.T

Latest Trade

8,500.00JPY

Change

-70.00(-0.82%)

Volume

81,700

Today's Range

8,500.00

 - 

8,610.00

52 Week Range

7,470.00

 - 

9,870.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
8,570.00
Open
8,510.00
Volume
81,700
3M AVG Volume
2.20
Today's High
8,610.00
Today's Low
8,500.00
52 Week High
9,870.00
52 Week Low
7,470.00
Shares Out (MIL)
78.16
Market Cap (MIL)
697,425.00
Forward P/E
--
Dividend (Yield %)
0.86

Next Event

Kobayashi Pharmaceutical Co Ltd Annual Shareholders Meeting

Latest Developments

More

Kobayashi Pharmaceutical Co Ltd Says To Buy Back Up To 1.64 Percent Of Own Shares Worth 8 Billion Yen Through Aug. 31

Kobayashi Pharmaceutical in deal to buy cosmetics firm True Nature

R&I affirms Kobayashi Pharmaceutical's rating at "A" and says stable outlook -R&I

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Kobayashi Pharmaceutical Co Ltd

KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.

Contact Info

KDX Kobayashi Doshomachi Bldg.

4-4-10, Dosho-machi, Chuo-ku

+81.6.62311144

https://www.kobayashi.co.jp/

Executive Leadership

Kazumasa Kobayashi

Chairman of the Board, Chairman of Subsidiary, Representative Director

Akihiro Kobayashi

President, Executive Officer, Representative Director

Yutaka Kobayashi

Vice Chairman of the Board, Representative Director

Satoshi Yamane

Senior Managing Director, Executive Officer, Chief Senior Director of Group Main Office

Susumu Horiuchi

Managing Director, Executive Officer, Chief Director of Sales

Key Stats

3.20 mean rating - 10 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

0.2K

2018

0.2K

2019

0.2K

2020(E)

0.2K
EPS (JPY)

2017

201.310

2018

228.050

2019

244.080

2020(E)

261.217
Price To Earnings (TTM)
34.80
Price To Sales (TTM)
4.15
Price To Book (MRQ)
3.85
Price To Cash Flow (TTM)
29.98
Total Debt To Equity (MRQ)
0.52
LT Debt To Equity (MRQ)
0.40
Return on Investment (TTM)
10.82
Return on Equity (TTM)
8.28

Latest News

Latest News

BRIEF-Kobayashi Pharmaceutical says private placement of treasury stock

* Says it will distribute 850,000 shares of its treasury common stock at 1 yen per share through private placement to The Master Trust Bank of Japan, Ltd.

BRIEF-R&I affirms Kobayashi Pharmaceutical's rating at "A" and announces stable outlook-R&I

* Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A" -R&I

CORRECTED-TABLE-Kobayashi Pharmaceutical-Q1 group results

Kobayashi Pharmaceutical Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 3 months ended 3 months ended Year to Mar 31, 2017 Jun 30, 2016 Dec 31, 2017 LATEST LATEST RESULTS RESULTS FORECAST Sales 30.75 36.77 150.00 Operating 4.96 7.30 20.00...

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up